Correction: Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures.
Alexia Verroken;
Lydwine Defourny;
Olivier le Polain de Waroux 
;
Leïla Belkhir;
Pierre-François Laterre;
Michel Delmée;
Youri Glupczynski;
(2016)
Correction: Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures.
PLOS ONE, 11 (9).
e0160537-.
ISSN 1932-6203
DOI: 10.1371/journal.pone.0160537
;
Leïla Belkhir;
Pierre-François Laterre;
Michel Delmée;
Youri Glupczynski;
(2016)
Correction: Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures.
PLOS ONE, 11 (9).
e0160537-.
ISSN 1932-6203
DOI: 10.1371/journal.pone.0160537
[This corrects the article DOI: 10.1371/journal.pone.0156299.].
-
picture_as_pdf - Correction Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatme.pdf
-
subject - Published Version
-
- Available under Creative Commons: 3.0
Downloads